EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry

Giuseppe Tarantini, Luca Nai Fovino, Héctor Alfonso Alvarez Covarrubias, Rafał Wolny, Tommaso Fabris, Joanna Nawara Skipirzepa, Matthias Eden, Jose Luis Zamorano, Michael Joner, Thomas Cuisset, Victoria Delgado, Josep Rodés-Cabau und 48 weitere

EuroIntervention · 2026-06 · 22 (11) · e629-e641

DOI: 10.4244/eij-d-25-01268 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift EuroIntervention, 2026-06. Verfasst von Giuseppe Tarantini und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Heart Valve Prosthesis, Aortic Valve. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transcatheter aortic valve implantation (TAVI) is increasingly performed in younger and lower-risk patients. Since many of these patients will outlive their transcatheter heart valve (THV), redo-TAVI procedures are expected to rise in number. Yet, real-world evidence on the procedural safety and efficacy of redo-TAVI remains limited. AIMS: We aimed to evaluate the 30-day procedural and clinical outcomes of redo-TAVI using the balloon-expandable SAPIEN 3 platform. METHODS: The ReTAVI registry is a prospective, international study enrolling consecutive patients with a failed aortic THV undergoing redo-TAVI with a balloon-expandable SAPIEN 3 THV. Data were collected across 59 international centres. All imaging was centrally analysed, and major clinical events were adjudicated by an independent committee. RESULTS: â¨A total of 143 patients (median age 84 years; 40.6% female; median Society of Thoracic Surgeons risk score 7.0%) were enrolled. The predominant failing THVs were balloon-expandable SAPIEN 3 (30.1%), self-expanding CoreValve/Evolut (53.1%), and ACURATE (14.0%) platforms. The most common failure mode was isolated regurgitation (48.6%), followed by stenosis (35.2%) and a mixed pathology (16.2%). The replacement valve was successfully implanted in 95.1% of patients, with a 30-day mortality rate of 3.5%. The 30-day stroke and pacemaker implantation rates were 0.7% and 6.3%, respectively. Redo-TAVI significantly improved valve haemodynamics, with mean gradients decreasing overall (Δ=-12.0 mmHg), and a more pronounced reduction in stenotic failures (Δ=-29.0 mmHg). Coronary obstruction was observed in 1.4% of cases. CONCLUSIONS: Redo-TAVI with a balloon-expandable SAPIEN 3 THV platform is a safe and effective reintervention strategy across diverse failed THV types, when guided by the Heart Team, standardised procedural planning, and comprehensive imaging. CLINICALTRIALS: gov: NCT05601453.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve StenosisHeart Valve ProsthesisAortic ValveHumansFemaleAged, 80 and overRegistriesProspective StudiesTreatment OutcomeMaleAgedReoperationProsthesis Design

Autor:innen und Institutionen

  • Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Department of Cardiology, TUM University Hospital German Heart Centre, School of Medicine and Health, Technical University Munich, Munich, Germany.
  • Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland.
  • Department of Cardiology and Structural Heart Disease, Medical University of Silesia, Katowice, Poland.
  • Department of Internal Medicine III (Cardiology, Angiology, Pneumology), Heidelberg University Clinic, Heidelberg, Germany.
  • University Hospital Ramón y Cajal, Madrid, Spain.

Zitieren

APA

Tarantini, G., Fovino, L. N., Alvarez Covarrubias, H. A., Wolny, R., Fabris, T., Skipirzepa, J. N., Eden, M., Zamorano, J. L., Joner, M., Cuisset, T., Delgado, V., Rodés-Cabau, J., Saia, F., Bieliauskas, G., Van Belle, E., Modine, T., Rheude, T., Garot, P., Jung, C., …, & Tóth-Gayor, G. (2026). Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry. EuroIntervention, 22(11), e629-e641. https://doi.org/10.4244/eij-d-25-01268

Vancouver

Tarantini G, Fovino LN, Alvarez Covarrubias HA, Wolny R, Fabris T, Skipirzepa JN, et al. Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry. EuroIntervention. 2026;22(11):e629-e641. doi:10.4244/eij-d-25-01268

BibTeX
@article{Tarantini2026,
  author = {Tarantini, Giuseppe and Fovino, Luca Nai and Alvarez Covarrubias, Héctor Alfonso and Wolny, Rafał and Fabris, Tommaso and Skipirzepa, Joanna Nawara and Eden, Matthias and Zamorano, Jose Luis and Joner, Michael and Cuisset, Thomas and Delgado, Victoria and Rodés-Cabau, Josep and Saia, Francesco and Bieliauskas, Gintautas and Van Belle, Eric and Modine, Thomas and Rheude, Tobias and Garot, Philippe and Jung, Christian and Rudolph, Tanja K and Leroux, Lionel and Rottbauer, Wolfgang and Nestelberger, Thomas and Lhermusier, Thibault and Nejjari, Mohammed and Regueiro, Ander and Meier, David and Fraccaro, Chiara and Hartikainen, Tau and Karam, Nicole and Swaans, Martin and Rodrigues, Alberto and Dreger, Henryk and Hengstenberg, Christian and Schmitz, Thomas and Mauler-Wittwer, Sarah and Piazza, Nicolo and Combaret, Nicolas and Letocart, Vincent and Auffret, Vincent and Durand, Eric and Urena-Alcázar, Marina and Del Valle-Fernández, Raquel and Drago, Andrea and De Carlo, Marco and Jimenez Diaz, Victor Alfonso and Dąbrowski, Maciej and Mascherbauer, Julia and Sudre, Arnaud and Ong, Peter and Gonska, Birgid and Mancone, Massimo and Fabris, Enrico and Teles, Rui Campante and Nombela-Franco, Luis and Asmarats, Lluis and Vilalta, Victoria and Protasiewicz, Marcin and Webb, John Graydon and Tóth-Gayor, Gábor},
  title = {Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry},
  journal = {EuroIntervention},
  year = {2026},
  volume = {22},
  number = {11},
  pages = {e629--e641},
  doi = {10.4244/eij-d-25-01268}
}
Kostenlos starten →